541 filings
Page 16 of 28
CORRESP
2chfeu iapx72nukdd
2 May 18
Correspondence with SEC
12:00am
8-K
u9jbcdb60
20 Apr 18
Other Events
12:00am
FWP
7vkjo4ng8rj 5jxc
20 Apr 18
Free writing prospectus
12:00am
CORRESP
b0mj6h0a fgaov1xuoh7
19 Apr 18
Correspondence with SEC
12:00am
UPLOAD
2vjwdn4 9t7rcse4hims
13 Apr 18
Letter from SEC
12:00am
8-K
d5z8qxc
26 Mar 18
Heat Biologics Reports Positive Data to Further Support the Mechanism of Action for its Proprietary T-Cell Activation Platform
12:00am
8-K
icl25f9kj8l kjgstr
19 Mar 18
Heat Biologics and its Pelican Therapeutics Subsidiary Appoint Anthony Tolcher, M.D., FRCPC, FACP to their Scientific Advisory Boards
12:00am
424B5
qlw9ju c6q5lr6
16 Mar 18
Prospectus supplement for primary offering
12:00am
8-A12B
itn s4mf7x5da
12 Mar 18
Registration of securities on exchange
12:00am
8-K
qq2dm fctw2jgxj7oz
12 Mar 18
Entry into a Material Definitive Agreement
12:00am
8-K
n78 6xwzi8r
6 Mar 18
Heat Biologics Corporate PresentationMarch 2018
12:00am
8-K
8pppmf
2 Mar 18
Heat Biologics Reports Fiscal Year 2017 Financial Results
12:00am
8-K
jgc6qu e5
28 Feb 18
Heat Biologics Announces Positive Interim Data from its Phase 2 Clinical Trial of
12:00am
8-K
o2xmxeu8v3 x5xqb6
20 Feb 18
Other Events
12:00am
8-K
dbaj6pgrzz
7 Feb 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
szm yxxkvjebnn
19 Jan 18
Heat Biologics Announces Reverse Stock Split
12:00am